Literature DB >> 15652207

In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice.

Sophia G Antimisiaris1, Pavlos Klepetsanis, Venetia Zachariou, Eleftheria Giannopoulou, Panagiotis V Ioannou.   

Abstract

We recently showed that arsonoliposomes (novel arsenic containg liposomes) demonstrate differential toxicity towards various types of cancer and normal cells, in cell culture studies, as well as anti-parasitic activity. In this study, the in-vivo distribution of the active moiety of these vesicles, As, is evaluated. Sonicated arsonoliposomes were prepared using the arsonolipid with palmitic acid acyl chain (C16) mixed with egg-phosphatidyl choline (PC) and cholesterol (Chol) [C16/PC/Chol at 8:12:10 mol/mol/mol]. A dose of arsonoliposomes, corresponding to 5 mg arsenate/kg was administered by intraperitoneal injection in balb-c mice. At various time points post-injection the mice were sacrificed and the distribution of As in the organs was measured, by atomic absorption spectroscopy. Results demonstrate that a high portion of the dose administered is rapidly excreted; since 1-h post-injection only about 30% of the dose administered was detected cumulatively in the animal tissues. After this the elimination of arsenic was a slow process with a total body elimination rate constant of 0.023 h(-1), corresponding to a half-life of 30 h. Tissues with the highest arsenic concentration during the study period are: spleen-kidneys-stomach, followed by lung, liver, intestines-heart, carcass+skin and finally blood. No acute toxicity, or effect on the body or organ weight of the mice was observed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652207     DOI: 10.1016/j.ijpharm.2004.11.002

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study.

Authors:  Raphaelle Fanciullino; Sarah Giacometti; Claude Aubert; Frederic Fina; Pierre-Marie Martin; Philippe Piccerelle; Joseph Ciccolini
Journal:  Pharm Res       Date:  2005-10-21       Impact factor: 4.200

2.  Novel Arsenic Nanoparticles Are More Effective and Less Toxic than As (III) to Inhibit Extracellular and Intracellular Proliferation of Leishmania donovani.

Authors:  Sudipta Chakraborty; Kaushik Bhar; Sandip Saha; Rajarshi Chakrabarti; Anjali Pal; Anirban Siddhanta
Journal:  J Parasitol Res       Date:  2014-12-31

3.  Synthesis of Novel Arsonolipids and Development of Novel Arsonoliposome Types.

Authors:  Spyridon Mourtas; Konstantina Papadia; Golfo G Kordopati; Panayiotis V Ioannou; Sophia G Antimisiaris; Gerasimos M Tsivgoulis
Journal:  Pharmaceutics       Date:  2022-08-08       Impact factor: 6.525

4.  Preparation, Physicochemical Properties, and In Vitro Toxicity towards Cancer Cells of Novel Types of Arsonoliposomes.

Authors:  Paraskevi Zagana; Spyridon Mourtas; Anastasia Basta; Sophia G Antimisiaris
Journal:  Pharmaceutics       Date:  2020-04-06       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.